Literature DB >> 12824843

Morning glory syndrome: association with moyamoya disease, midline cranial defects, central nervous system anomalies, and persistent hyaloid artery remnant.

Ibrahim Taşkintuna1, Ozay Oz, Mehmet Y Teke, Halit Koçak, Esin Firat.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12824843     DOI: 10.1097/00006982-200306000-00018

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  6 in total

1.  Bilateral peripapillary staphyloma, a clinicoradiological report.

Authors:  M S Sanjari; K Ghasemi Falavarjani; M B Kashkouli
Journal:  Br J Ophthalmol       Date:  2006-10       Impact factor: 4.638

2.  The clinical characteristics and imaging findings of morning glory syndrome.

Authors:  Jun Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-08-15

3.  Morning glory disc anomaly associated with moyamoya disease and pituitary stalk duplication.

Authors:  Mohamed M Khodeiry; Viet Q Chau; Anas Yasin; Robert M Starke; Shahnaz Miri; Joshua Pasol
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-24

4.  Pituitary stalk duplication in association with moya moya disease and bilateral morning glory disc anomaly - broadening the clinical spectrum of midline defects.

Authors:  T Loddenkemper; N R Friedman; P M Ruggieri; A Marcotty; J Sears; E I Traboulsi
Journal:  J Neurol       Date:  2008-03-20       Impact factor: 4.849

5.  Distinctive facial features in idiopathic Moyamoya disease in Caucasians: a first systematic analysis.

Authors:  Markus Kraemer; Quoc Bao Huynh; Dagmar Wieczorek; Brunilda Balliu; Barbara Mikat; Stefan Boehringer
Journal:  PeerJ       Date:  2018-06-27       Impact factor: 2.984

6.  A rare triad of morning glory disc anomaly, moyamoya vasculopathy, and transsphenoidal cephalocele: pathophysiological considerations and surgical management.

Authors:  Marco Pavanello; Pietro Fiaschi; Andrea Accogli; Mariasavina Severino; Domenico Tortora; Gianluca Piatelli; Valeria Capra
Journal:  Neurol Sci       Date:  2021-04-06       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.